Garmin expands ECG App to customers in New Zealand
Customers can now record an ECG and check for signs of atrial fibrillation right from their compatible Garmin smartwatch
Garmin today announced the ECG App is now available to customers in New Zealand with a compatible Garmin smartwatch, including Venu® 3 Series, fēnix® 8 Series and more1,2. The ECG App allows users to record their heart rhythm and check for signs of atrial fibrillation (AFib) whenever they want. Customers can use the ECG App to record a 30-second ECG and view their heart rhythm results immediately on the watch or, optionally, later in the Garmin Connect™ smartphone app.
“The ECG App is Garmin’s first smartwatch feature categorised as a medical device in New Zealand, and we are thrilled to offer this revolutionary tool to more customers as another way to stay on top of their health. During the early stages of AFib, it’s common for symptoms to be infrequent, making it difficult to detect in a clinical setting. With the ECG App, customers can conveniently take an ECG recording when they want and optionally create a report of their results to share with their doctor later.”
—Susan Lyman, Garmin Vice President Consumer Sales & Marketing
When customers take an ECG, the ECG App uses sensors on a compatible Garmin smartwatch to record the electrical signals that control how their heart beats. The ECG App then analyses that recording to detect signs of AFib. Additionally, users have the option to sync their ECG App results to Garmin Connect. Through the Garmin Connect app, customers can view their history of ECG App results and create reports that can be shared with a healthcare provider.
The ECG App is now available for customers in New Zealand and requires the latest version of the Garmin Connect app and smartwatch software before use. Garmin intends to continue to expand its portfolio of products supporting the ECG App and launch it in new regions in-line with necessary regulatory approval. For more information on the ECG App and how to set it up, visit Garmin.com/ECG.
Engineered on the inside for life on the outside, Garmin products have revolutionised the wellness industry. Committed to developing wearables and health measurement tools that help people of all activity levels lead healthier lives, Garmin believes every day is an opportunity to innovate and a chance to beat yesterday. For more information, visit Garmin’s virtual newsroom, email our press team, connect with @garminau on social media, or follow our adventures at garmin.com/blog.
1 The ECG app is capable of recording an ECG similar to a Lead I ECG and detecting the presence of atrial fibrillation or normal sinus rhythm. The ECG app is only intended for adults aged 22 years and over. The ECG app is not intended to replace traditional methods of diagnosis or treatment. Do not use if you have a known arrythmia other than atrial fibrillation or if you are pregnant. If atrial fibrillation is detected, consult a doctor. If you experience symptoms of a heart attack, stroke, or other cardiovascular conditions, do not rely on the notification of the device and consult a doctor. Always follow the instructions for use. The ECG app is not available in all regions and is only available on select Garmin smartwatches with the latest version of the Garmin Connect smartphone app and watch software. See Garmin.com/ECG for availability and full instructions for use. Garmin International, Inc., USA.
2 Visit Garmin.com/ECG for a full list of compatible devices.
###
About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin, Venu and fēnix are registered trademarks and Garmin Connect is a trademark of Garmin Ltd. or its subsidiaries. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.
Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management’s current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 30, 2023, filed by Garmin with the Securities and Exchange Commission (Commission file number 0001-411180). A copy of such Form 10-K is available at http://www.garmin.com/aboutGarmin/invRelations/finReports.html. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
MEDIA CONTACTS:
